CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Shanghai Rendu Biotechnology Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Shanghai Rendu Biotechnology Co Ltd
F3 Block 7 #590 Ruiqing Rd
East Zone, Zhangjiang High- Tech Park
Phone: +86 2150720069p:+86 2150720069 Shanghai, SHA  201201  China Ticker: 688193688193
Business Summary
Shanghai Rendu Biotechnology Co Ltd is a China-based company mainly engaged in the research, development and sales of molecular diagnostic reagents. The Company utilizes ribonucleic acid (RNA) isothermal amplification technology to provides multiple series of diagnostic reagents, including respiration series, reproduction series, enterovirus series, blood-borne diseases series and other diagnostic reagents. The Company also designs and manufactures medical instruments. The Company mainly sells its products within domestic market.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202412/31/2023Yes----

Industries
SIC Code Description
2835 In vitro and in vivo diagnostic substances
3841 Surgical and medical instruments and apparatus

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, Chief Scientific Officer JinliangJu 57 6/1/2007 6/1/2007
Chief Financial Officer, Secretary of the Board TingjiangCai 48 10/1/2020 8/1/2015
General Manager, Director MinghuiYu 40 12/9/2022 12/1/2013
5 additional Officers and Directors records available in full report.

General Information
Number of Employees: 358 (As of 12/31/2023)
Outstanding Shares: 40,000,000 (As of 9/30/2024)
Shareholders: 4,324
Stock Exchange: SHA
Fax Number: +86 2150720069


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, November 20, 2024